Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis.

Yuqing ZhangXiaoxin ZhangLifan LinMingzhao Xing

Published in: The Journal of clinical endocrinology and metabolism (2024)

The currently used targeted drug therapies for RR-DTC can significantly improve clinical outcomes and the new drug apatinib demonstrates promise for potentially superior performance.

Keyphrases

adverse drug
big data
emergency department
drug delivery
artificial intelligence